Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/15/2025

Diagnostic Approach to Late-Onset Dementia

Initial Assessment and Warning Signs

  • The American Academy of Neurology recommends evaluating suspected late-onset dementia by remaining vigilant for warning signs including missed appointments, difficulty following instructions, unexplained decline in instrumental activities of daily living, or new-onset behavioral changes in older adults 1, 2
  • Reported cognitive symptoms by patient or informant should be noted, as well as missed appointments or showing up at incorrect times, difficulty remembering or following medication instructions, decrease in self-care abilities, and new-onset depression or anxiety in later life 1, 2

High-Risk Populations

  • Actively inquire about cognitive concerns in patients with a history of stroke or TIA, late-onset depressive disorder, untreated sleep apnea, recent delirium episode, Parkinson's disease, recent head injury, or first major psychiatric episode at advanced age 1, 2

Cognitive Assessment Tools

  • The American Academy of Neurology recommends using the Montreal Cognitive Assessment (MoCA) when mild cognitive impairment is suspected, as it is more sensitive than the MMSE for detecting early dementia 2, 3
  • Rapid screening options include the Memory Impairment Screen (MIS) + Clock Drawing Test, Mini-Cog, AD8, and Four-item MoCA (Clock-drawing, Tap-at-letter-A, Orientation, Delayed-recall) 1, 2

Mandatory Laboratory Workup

  • Core laboratory investigations must include complete blood count, comprehensive metabolic panel, thyroid function tests (TSH, free T4), vitamin B12 and folate levels, and liver function tests 3

Neuroimaging Requirements

  • MRI is preferred over CT for anatomical neuroimaging, especially for detecting vascular lesions 3, 4

Non-Cognitive Markers to Assess

  • Routinely assess gait speed, parkinsonism, frailty, hearing impairment, sleep history, and neuropsychiatric symptoms in memory clinic settings 5, 6

Pharmacological Treatment

  • The American Academy of Neurology recommends initiating cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) for mild to moderate Alzheimer's disease dementia 3
  • Add memantine for moderate to severe dementia, either alone or combined with a cholinesterase inhibitor 3

Non-Pharmacological Interventions

  • Prescribe aerobic exercise and/or resistance training of at least moderate intensity to improve cognitive outcomes 6, 3
  • Recommend adherence to Mediterranean diet with high mono- and polyunsaturated fatty acids and low saturated fatty acids 6, 3

Follow-Up and Monitoring

  • Schedule follow-up visits every 6-12 months using a multi-dimensional approach assessing cognitive function, functional autonomy, behavioral symptoms, and caregiver burden 3, 7, 4